Initial Experience with the 6–10 mm TIPS Endoprosthesis: Technical Feasibility and Early Clinical Outcomes
Year: 2026
Type: article
Study design: Observational Study
Abstract: PURPOSE: To evaluate the technical feasibility, hemodynamic effects, and early clinical outcomes of the 6-10 mm GORE VIATORR TIPS Endoprosthesis with Controlled Expansion, which extends the prior 8 mm deployment floor to 6 mm. MATERIALS AND METHODS: This single-center retrospective study included consecutive patients who underwent de novo transjugular intrahepatic portosystemic shunt (TIPS) creation with the 6-10 mm device between April and July 2026. Technical success was defined as portosystemic pressure gradient (PSPG) below 12 mmHg or ≥ 50% reduction from baseline. RESULT: Twelve patients (8 females, 4 males; mean age 57.1 ± 15.7 years; range 32-83 years) were included. Indications for TIPS creation were variceal hemorrhage (50.0%; n = 6/12), refractory ascites (33.3%; n = 4/12), and refractory hepatic hydrothorax (16.7%; n = 2/12). Final stent diameter was less than 8 mm in 91.7% (n = 11/12) of patients. Technical success was achieved in all patients, with mean PSPG decreasing from 16.7 ± 7.7 to 7.7 ± 2.9 mmHg (P < .001) and no immediate adverse events. Shunt patency was 100% at short imaging follow-up (mean, 35.6 ± 25.0 days), with no reinterventions. No recurrent variceal hemorrhage occurred, and ascites improved or resolved in 77.8% (n = 7/9) of patients at short clinical follow-up (mean, 50.5 ± 23.3 days). Four of 11 patients (36.4%) experienced symptomatic HE after TIPS creation and one patient (9.1%) died during the follow-up period. CONCLUSION: TIPS creation using the 6-10 mm device is a technically feasible strategy with adequate short-term hemodynamic response.
Institution: University of Southern California
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $4,490
OpenAlex ID: W7233750224
